Kapa Biosystems Strengthens Leadership Team and Doubles Global Facility Investment
WILMINGTON, Mass. – Kapa Biosystems, Inc., a leading supplier of reagents for the life science market, today announced several high-profile additions to its management team, along with the relocation of its corporate and international headquarters to larger facilities in Wilmington, Mass. and Cape Town, South Africa respectively. Combined, these new locations offer more than 25,000 square feet, which more than doubles the company’s previous facility investment. These new hires and larger facilities enable the company to scale enzyme production, quality control and manufacturing capacity across its four business franchises, increase headcount and expand R&D initiatives to better serve its growing number of customers around the world.
“Over the past eight years, Kapa Biosystems has transformed from a startup with a proprietary protein engineering technology platform to a global commercial organization with a best-in-class portfolio of products for genomics research and diagnostic applications,” said Christopher McGuinness, Co-Founder and Chief Operating Officer at Kapa Biosystems. “With these recent additions to our leadership team and the larger facilities, we now have the expertise and resources needed to deliver more enabling product solutions, develop more strategic business partnerships and drive more widespread customer adoption.”
Experienced Leadership Team Appointments
As part of its corporate growth strategy, Kapa Biosystems recently hired four industry veterans to lead key business functions. These new team members bring significant experience in operations, sales and marketing to support growing life science companies.
- Kobus Lindeque, Managing Director, South Africa Facility
Mr. Lindeque will oversee the research, production and manufacturing capabilities and all day-to-day operations at the Cape Town facility. He brings more than 30 years of industry experience and spent the past 15 years at Monsanto Company. Prior to joining Kapa Biosystems, he was the Managing Director for Monsanto Africa and was responsible for the entire Sub Sahara business and more than 350 employees. Under his leadership, the company experienced consistent year over year growth and a market increase of more than 50 percent in South Africa and more than 8 percent in the rest of the continent.
- Jean-Christophe Hatinguais, Director, International Sales
Mr. Hatinguais will be responsible for growing the PCR, qPCR and NGS product franchises around the world and directing more than 50 of the company’s global distributors. He brings more than 30 years of experience in various sales, marketing and management roles at leading life science and biotechnology companies such as QIAGEN N.V., Mettler-Toledo International Inc., Applied Biosystems Corp., and Waters Corp. As the Vice President Sales Life Sciences / EMEA at QIAGEN, he managed more than 130 employees across 14 countries and helped drive more than $180 million in sales.
- Chris Tierney, Director, Business Development
Mr. Tierney will focus on pursuing new business opportunities and developing and maintaining effective strategic corporate relationships. Mr. Tierney brings more than 15 years of business development, sales management and sales experience at leading life science technology companies, including Thermo Fisher Scientific Inc., Dharmacon Inc. and QIAGEN N.V. His accomplishments include negotiating strategic OEM agreements and executing milestone-driven development projects with major Life Science partners.
- Brian Komorous, Director, Marketing
Mr. Komorous will be responsible for the organization’s marketing strategies, product management plans and communications activities. He brings more than 10 years of experience at companies such as RainDance Technologies Inc., Beckman Coulter Genomics and BD Diagnostics. At RainDance Technologies, he oversaw the targeted sequencing business franchise and built the company’s commercial partnership program with the leading clinical genomic testing centers.
The company plans on filling the new office space by making additional hires for positions across a range of scientific, technical, marketing, and sales disciplines. For more information on available positions, please visit:http://www.kapabiosystems.com/company/careers.
About Kapa Biosystems
Kapa Biosystems is a life science reagents supplier that employs proprietary, directed evolution technologies to optimize enzymes for PCR, real-time PCR, next generation sequencing and molecular diagnostic applications. Kapa Biosystems offers a portfolio of best-in-class products containing novel enzymes that confer significant performance advantages when compared to traditional wild-type enzymes. The company is based in Wilmington, Massachusetts with a research, development and manufacturing facility in Cape Town, South Africa. For more information, please visit www.kapabiosystems.com
KAPA is a trademark of Kapa Biosystems. All other brands may be trademarks of their respective holders.
Kapa Biosystems’ products are for Research Use Only; not for use in diagnostic procedures.